carvedilol has been researched along with Idiopathic Parkinson Disease in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is a nonselective β & α1 blocker with additional effects as an antioxidant, anti-inflammatory and neuro protective properties." | 1.72 | Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study. ( Ahmed, HI; Albohy, A; Azab, SS; Kamal, RE; Menze, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamal, RE | 1 |
| Menze, E | 1 |
| Albohy, A | 1 |
| Ahmed, HI | 1 |
| Azab, SS | 1 |
1 other study available for carvedilol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carvedilol; Glial Fibrillary Acidic Protein; Glycog | 2022 |